Clearline Capital’s Chemours CC Stock Holding History

Clearline Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,602	Closed	-$428K	–	143
2022 Q1	$428K	Hold	13,602	–	–	0.05%	110
2021 Q4	$456K	Hold	13,602	–	–	0.05%	115
2021 Q3	$395K	Buy	+13,602	New	+$440K	0.04%	126

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clearline Capital's CC Position: Q2 2022 in Review

Clearline Capital sold out of Chemours (CC) in Q2 2022, closing a stake of 13,602 shares — an estimated $428K sold.

Clearline Capital first reported a position in CC in Q3 2021 and held it in 3 quarters. The position peaked at $456K in Q4 2021. 517 funds tracked by Wall St. Rank hold CC as of Q2 2022.

Clearline Capital reported no remaining Chemours position as of Q2 2022 after selling out during the quarter.
Clearline Capital sold 13,602 Chemours shares in Q2 2022, an estimated $428K.
Clearline Capital first reported a position in Chemours in Q3 2021 and held it in 3 quarters.
Clearline Capital's Chemours position peaked at $456K in Q4 2021.
517 funds tracked by Wall St. Rank held Chemours as of Q2 2022.

Based on Clearline Capital's 13F filing for Q2 2022, filed 15 Aug 2022.